FDA Backs Maternal RSV Vaccine, Study Pfizer Safety Concerns Later
globalcommunityweekly.substack.com
FDA Backs Maternal RSV Vaccine, Study Pfizer Safety Concerns Later
Shots now. Ask questions later........ and of course a special law was passed by Congress & Biden so that Pfizer never has any liability for anything they do!
FDA Advisers Back Maternal RSV Vaccine As Pfizer Says Safety Concerns Can Be Studied Post-Approval
SUNDAY, MAY 21, 2023
Advisers to the U.S. Food and Drug Administration (FDA) voiced support on May 18 for Pfizer’s maternal RSV vaccine even after several expressed concerns over premature births.
Keep reading with a 7-day free trial
Subscribe to Global Community Weekly (GloCom) to keep reading this post and get 7 days of free access to the full post archives.